NEPH
Price
$3.57
Change
+$0.13 (+3.78%)
Updated
Jul 25 closing price
Capitalization
23.09M
10 days until earnings call
STRRP
Price
$9.09
Change
-$0.04 (-0.44%)
Updated
Jul 25 closing price
Capitalization
N/A
Interact to see
Advertisement

NEPH vs STRRP

Header iconNEPH vs STRRP Comparison
Open Charts NEPH vs STRRPBanner chart's image
Nephros
Price$3.57
Change+$0.13 (+3.78%)
Volume$22.95K
Capitalization23.09M
Star Equity Holdings
Price$9.09
Change-$0.04 (-0.44%)
Volume$346
CapitalizationN/A
NEPH vs STRRP Comparison Chart in %
Loading...
NEPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STRRP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NEPH vs. STRRP commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NEPH is a Hold and STRRP is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (NEPH: $3.57 vs. STRRP: $9.09)
Brand notoriety: NEPH and STRRP are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: NEPH: 49% vs. STRRP: 28%
Market capitalization -- NEPH: $23.09M vs. STRRP: $0
NEPH [@Medical Specialties] is valued at $23.09M. STRRP’s [@Medical Specialties] market capitalization is $0. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.76B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NEPH’s FA Score shows that 0 FA rating(s) are green whileSTRRP’s FA Score has 1 green FA rating(s).

  • NEPH’s FA Score: 0 green, 5 red.
  • STRRP’s FA Score: 1 green, 4 red.
According to our system of comparison, STRRP is a better buy in the long-term than NEPH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NEPH’s TA Score shows that 3 TA indicator(s) are bullish while STRRP’s TA Score has 2 bullish TA indicator(s).

  • NEPH’s TA Score: 3 bullish, 5 bearish.
  • STRRP’s TA Score: 2 bullish, 5 bearish.
According to our system of comparison, STRRP is a better buy in the short-term than NEPH.

Price Growth

NEPH (@Medical Specialties) experienced а -2.06% price change this week, while STRRP (@Medical Specialties) price change was -0.15% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +3.05%. For the same industry, the average monthly price growth was +5.16%, and the average quarterly price growth was -1.87%.

Reported Earning Dates

NEPH is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Medical Specialties (+3.05% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NEPH YTD gains are higher at: 142.857 vs. STRRP (7.440). NEPH has higher annual earnings (EBITDA): -1.36M vs. STRRP (-1.69M). STRRP has more cash in the bank: 23.2M vs. NEPH (4.31M). NEPH has less debt than STRRP: NEPH (1.84M) vs STRRP (3.61M). STRRP has higher revenues than NEPH: STRRP (45.8M) vs NEPH (14.2M).
NEPHSTRRPNEPH / STRRP
Capitalization23.1MN/A-
EBITDA-1.36M-1.69M81%
Gain YTD142.8577.4401,920%
P/E RatioN/AN/A-
Revenue14.2M45.8M31%
Total Cash4.31M23.2M19%
Total Debt1.84M3.61M51%
FUNDAMENTALS RATINGS
NEPH vs STRRP: Fundamental Ratings
NEPH
STRRP
OUTLOOK RATING
1..100
902
VALUATION
overvalued / fair valued / undervalued
1..100
71
Overvalued
1
Undervalued
PROFIT vs RISK RATING
1..100
10035
SMR RATING
1..100
72100
PRICE GROWTH RATING
1..100
3758
P/E GROWTH RATING
1..100
98100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

STRRP's Valuation (1) in the null industry is significantly better than the same rating for NEPH (71). This means that STRRP’s stock grew significantly faster than NEPH’s over the last 12 months.

STRRP's Profit vs Risk Rating (35) in the null industry is somewhat better than the same rating for NEPH (100). This means that STRRP’s stock grew somewhat faster than NEPH’s over the last 12 months.

NEPH's SMR Rating (72) in the null industry is in the same range as STRRP (100). This means that NEPH’s stock grew similarly to STRRP’s over the last 12 months.

NEPH's Price Growth Rating (37) in the null industry is in the same range as STRRP (58). This means that NEPH’s stock grew similarly to STRRP’s over the last 12 months.

NEPH's P/E Growth Rating (98) in the null industry is in the same range as STRRP (100). This means that NEPH’s stock grew similarly to STRRP’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NEPHSTRRP
RSI
ODDS (%)
Bearish Trend 4 days ago
77%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
77%
Bearish Trend 3 days ago
41%
Momentum
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
45%
MACD
ODDS (%)
Bearish Trend 3 days ago
61%
Bearish Trend 3 days ago
47%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
80%
Bearish Trend 3 days ago
43%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
78%
Bullish Trend 3 days ago
44%
Advances
ODDS (%)
Bullish Trend 10 days ago
76%
Bullish Trend 25 days ago
53%
Declines
ODDS (%)
Bearish Trend 6 days ago
82%
N/A
BollingerBands
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 3 days ago
43%
Aroon
ODDS (%)
Bullish Trend 3 days ago
88%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
NEPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STRRP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VIST44.500.70
+1.60%
Vista Energy SAB de CV
AVNS12.010.13
+1.09%
Avanos Medical
HEI323.743.34
+1.04%
HEICO Corp
CHMG52.39-0.43
-0.81%
Chemung Financial Corp
LITB1.25-0.06
-4.58%
LightInTheBox Holding Co Ltd

NEPH and

Correlation & Price change

A.I.dvisor indicates that over the last year, NEPH has been loosely correlated with IMDX. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if NEPH jumps, then IMDX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NEPH
1D Price
Change %
NEPH100%
+3.78%
IMDX - NEPH
34%
Loosely correlated
-2.53%
SGHT - NEPH
33%
Loosely correlated
-1.97%
NEO - NEPH
25%
Poorly correlated
-2.02%
VNRX - NEPH
22%
Poorly correlated
+2.70%
OFIX - NEPH
22%
Poorly correlated
+0.27%
More

STRRP and

Correlation & Price change

A.I.dvisor tells us that STRRP and POAI have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that STRRP and POAI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STRRP
1D Price
Change %
STRRP100%
-0.43%
POAI - STRRP
25%
Poorly correlated
-0.08%
STRR - STRRP
21%
Poorly correlated
-2.33%
NSYS - STRRP
20%
Poorly correlated
-0.93%
NEPH - STRRP
20%
Poorly correlated
+3.78%
VMD - STRRP
20%
Poorly correlated
-2.70%
More